BSD Medical's Stellar Performance

BSD Medical Corp. (BSDM) up 79 cents to 3.94, a nice percentage gain today. The stock did so well it made Harry Boxer's Chart of the Day on The Technical Trader. View the Chart Here.

Wikinvest---BSD Medical Corporation (NASDAQ:BSDM) went up 25.08% to $3.94 on over 3.07 million shares. BSD Medical Corporation develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency (RF) or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies.

So far, the market capitalization of the stock stands at $103.14 million and average daily volume of the stock is 1.29 million shares. Today, the stock made its fresh 52-week high of $4.08.

September 29, 2010

BSD Medical Obtains Patent on Innovative Design for Heat Therapy Devices

BSD Medical's Stock is Rising Fast: BSDM

BSD Medical is going up like hotcakes these days. I still think there is plenty of room for future growth. Today's trading is BSDM 3.16 +0.19 (6.40%) They recently had FDA approval for cancer treatment medical device. I don't think it's too late to get on board with this stock and see it as a real Long Term Growth Potential. They are selling their newly acquired 510K approved products at a rapid pace to Cancer Treatment centers across the country.

Wikinvest is a great Market Tool: BSD Medical




Texas Oncology Acquires Hyperthermia System from BSD Medical

BSD Medical receives FDA clearance for MTX-180

Image via CrunchBase SALT LAKE CITY, Aug 18, 2010 (BUSINESS WIRE) -- BSD Medical Corporation /quotes/comstock/15*!bsdm/quotes/nls/bsdm (BSDM 1.82, +0.69, +61.06%) (Company or BSD) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.

BioPharma List for Wednesday August 11th

Stocks that I will be following for the near future. Yesterday's market was down heavy due to the FED's recommendation but we will see how the market recovers Wednesday. The FED acknowledged the economy needs help and was cashing in mortgage securities into long-term treasury notes.

Here are stocks I am currently following for Wednesday and interested by near future events.

1. BSD Medical BSDM

Three Extreme FDA Medical Device / Diagnostic Trades
by: Mike Havrilla June 03, 2010